Alpha 2.0
Login Register
» Authors » John Peabody

John Peabody

Explore the profile of John Peabody including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 38
Citations 559
Followers 0
Related Specialties
Health Services
General Medicine
Public Health
Top 10 Co-Authors
David Paculdo
Mary Tran
Czarlota Valdenor
Trever Burgon
Diana Tamondong-Lachica
Orville Solon
Stella Quimbo
Elaine Jeter
Jhiedon Florentino
M Czarina Acelajado
Published In
Diagnostics (Basel)
J Clin Med
Health Aff (Millwood)
Soc Sci Med
Occup Health Saf
Affiliations
Soon will be listed here.
Recent Articles
1.
The Impact of Fibular Fixation Method on Pilon Fracture Healing
Perugini A, Hyland S, Iandoli J, Hill Z, Peabody J, DeGenova D, et al.
J Clin Med . 2025 Jan; 14(2). PMID: 39860364
Pilon fractures are associated with high-energy injuries, and there is presently much debate as to optimal fixation strategies and timing of intervention. There is little evidence comparing the type of...
2.
Clinical Utility of a Biomarker to Detect Contrast-Induced Acute Kidney Injury during Percutaneous Cardiovascular Procedures
Peabody J, Paculdo D, Valdenor C, McCullough P, Noiri E, Sugaya T, et al.
Cardiorenal Med . 2022 Jan; 12(1):11-19. PMID: 35034025
Introduction: Contrast-induced acute kidney injury (CI-AKI) is a major clinical complication of percutaneous cardiovascular procedures requiring iodinated contrast. Despite its relative frequency, practicing physicians are unlikely to identify or treat...
3.
Measuring and Improving Evidence-Based Patient Care Using a Web-Based Gamified Approach in Primary Care (QualityIQ): Randomized Controlled Trial
Burgon T, Casebeer L, Aasen H, Valdenor C, Tamondong-Lachica D, de Belen E, et al.
J Med Internet Res . 2021 Dec; 23(12):e31042. PMID: 34941547
Background: Unwarranted variability in clinical practice is a challenging problem in practice today, leading to poor outcomes for patients and low-value care for providers, payers, and patients. Objective: In this...
4.
Initiative to Improve Evidence-Based Chronic Obstructive Pulmonary Disease Hospitalist Care Using a Novel On-Line Gamification Patient Simulation Tool: A Prospective Study
Strong J, Weems L, Burgon T, Branch J, Martin J, Paculdo D, et al.
Healthcare (Basel) . 2021 Oct; 9(10). PMID: 34682947
Chronic obstructive pulmonary disease (COPD) remains a leading cause of morbidity and mortality. Much of the disease burden comes from exacerbations requiring hospitalization. Unwarranted care variation and divergence from evidence-based...
5.
Randomized Trial to Improve Primary Care Patient Management and Patient Outcomes Using a Drug-Drug Interaction Test: Confirmation of the DECART Simulated Patient Clinical Utility Trial Results
Peabody J, Schrecker J, Heltsley R, Paculdo D, de Belen E, Tamondong-Lachica D, et al.
Diagnostics (Basel) . 2021 Aug; 11(7). PMID: 34359349
Drug-drug interactions (DDIs) are a serious problem in the healthcare system, leading to excess healthcare utilization and costs. We conducted a second prospective randomized, controlled trial to further establish the...
6.
Measuring the Variation in the Prevention and Treatment of CI-AKI Among Interventional Cardiologists
Valdenor C, McCullough P, Paculdo D, Acelajado M, Dahlen J, Noiri E, et al.
Curr Probl Cardiol . 2021 May; 46(9):100851. PMID: 33994040
Contrast-induced acute kidney injury (CI-AKI) occurs in up to 10% of cardiac catheterizations and coronary interventions, resulting in increased morbidity, mortality, and cost. One main reason for these complications and...
7.
Randomized Trial on the Clinical Utility of a Novel Biomarker Panel to Identify Treatable Determinants of Chronic Pain
Peabody J, Paculdo D, Tamondong-Lachica D, Cabaluna I, Gunn J
Diagnostics (Basel) . 2020 Jul; 10(8). PMID: 32717995
Millions suffer daily from chronic pain diagnosed anatomically and treated with opioids. Research shows that underlying nutritional, metabolic and oxidative stressors, which drive the development or worsening of chronic pain,...
8.
Randomized clinical trial of a novel donor-derived cfDNA test to detect rejection in CPV-simulated renal transplant patients
Peabody J, Billings P, Valdenor C, Demko Z, Moshkevich S, Tran M, et al.
Int Urol Nephrol . 2020 May; 52(8):1593-1601. PMID: 32415610
Purpose: Five-year kidney graft loss currently stands at about 30%. We evaluate the clinical utility of a blood test measuring donor-derived cell-free DNA that detects rejection earlier and, potentially, improves...
9.
Finding the clinical utility of 1,5-anhydroglucitol among primary care practitioners
Peabody J, Paculdo D, Acelajado M, Burgon T, Dahlen J
J Clin Transl Endocrinol . 2020 May; 20:100224. PMID: 32368501
Background: HbA1c is widely used as the standard measure to track glycemic control in patients with diabetes and pre-diabetes but measures average levels of glycated hemoglobin over two to three...
10.
Clinical Utility of a Blood-based Protein Assay on Diagnostic Colonoscopy Referrals for Elevated-risk Colorectal Cancer Patients in Primary Care
Peabody J, Rahim A, Wilcox B, McGehee C, Estigarribia E, Paculdo D, et al.
Am J Clin Oncol . 2019 Jul; 42(9):687-691. PMID: 31335349
Background: Colonoscopies are effective in finding early stage colorectal cancer (CRC), which when found in a timely manner, dramatically improve survival rates. A significant number of at-risk patients are still...